Reltio Launches Enterprise 360 Site Intelligence
Reltio, a cloud-native master data management software provider, has introduced Reltio Enterprise 360 Site Intelligence. The software centralizes detailed data about study sites and principal investigators. Features include the ability to search all current, complete, accurate information available on healthcare organizations/ study sites, and HCP/PIs; evaluate and rate study sites and principal investigators using artificial intelligence (AI), quantitative metrics, and qualitative criteria, and manage consent, contracting, and collaboration workflows.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025